Clinical manifestation of alcohol withdrawal symptoms related to genetic polymorphisms of two serotonin receptors and serotonin transporter

European Addiction Research

Volumn 15, Issue 1, 2008, Pages 39-46

  Lee, Young Sik ^a   Choi, Sam Wook ^b,e   Han, Doug Hyun ^a   Kim, Dai Jin ^c   Joe, Keun Ho ^d  

^a Chung Ang University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Eulji University   (South Korea)

^e Ulsan University College of Medicine   (South Korea)

Author keywords

Alcohol dependence; Alcohol withdrawal; Genetic polymorphism; Serotonin

Indexed keywords

SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER;

AGITATION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ALLELE; ANXIETY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEADACHE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPOACUSIS; KOREA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PROMOTER REGION; SWEATING; SYMPTOM; TACTILE DISCRIMINATION; TREMOR; VISUAL DISORDER; VOMITING;

ADULT; ALCOHOLISM; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 57049168665     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000173008     Document Type: Article

References (42)

1. Edenberg HJ, Foroud T: The genetics of alcoholism: Identifying specific genes through family studies. Addict Biol 2006;11:386-396.
2. Kalant H: Alcohol withdrawal syndromes in the human: comparison with animal models. Adv Exp Med Biol 1977;85B:57-64.
3. Newlin DB, Pretorius MB: Sons of alcoholics report greater hangover symptoms than sons of non-alcoholics: a pilot study. Alcohol Clin Exp Res 1990;14:713-716.
4. Hershon HI: Alcohol withdrawal symptoms and drinking behavior. J Stud Alcohol 1977;38:953-971.
5. Pristach CA, Smith CM, Whitney RB: Alcohol withdrawal syndromes - prediction from detailed medical and drinking histories. Drug Alcohol Depend 1983;11:177-199.
6. Schmidt LG, Sander T: Genetics of alcohol withdrawal. Eur Psychiatry 2000;15:135-139.
7. Faingold CL, Knapp DJ, Chester JA, Gonzalez LP: Integrative neurobiology of the alcohol withdrawal syndrome - from anxiety to seizures. Alcohol Clin Exp Res 2004;28:268-278.
8. 2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics 1997;7:271-281.
9. Gorwood P, Limosin F, Batel P, Hamon M, Ades J, Boni C: The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biol Psychiatry 2003;53:85-92.
10. Samochowiec J, Kucharska-Mazur J, Kaminski R, Smolka M, Rommelschpacher H, Wernicke C, Tymicz A, Schmidt LG: Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence. Psychiatry Res 2002;111:229-233.
11. Benkelfat C: Serotonergic mechanisms in psychiatric disorders: new research tools, new ideas. Int Clin Psychopharmacol 1993;8(suppl 2):53-56.
12. Heinz A, Goldman D: Genotype effects on neurodegeneration and neuroadaptation in monoaminergic neurotransmitter systems. Neurochem Int 2000;37:425-432.
13. Ulrichsen J: Alterations in serotonin receptor subtypes in ethanol-dependent rats. Alcohol Alcohol 1991;26:567-573.
14. Buckholtz NS, Zhou DF, Tabakoff B: Ethanol does not affect serotonin receptor binding in rodent brain. Alcohol 1989;6:277-280.
15. Maurel S, De Vry J, De Beun R, Schreiber R: 5-HT2A and 5-HT2C/5-HT1B receptors are differentially involved in alcohol preference and consummatory behavior in cAA rats. Pharmacol Biochem Behav 1999;62:89-96.
16. Fehr C, Schleicher A, Szegedi A, Anghelescu I, Klawe C, Hiemke C, Dahmen N: Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:965-982.
17. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP: Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66:2621-2624.
18. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-1531.
19. Matsushita S, Yoshino A, Murayama M, Kimura M, Muramatsu T, Higuchi S: Association study of serotonin transporter gene regulatory region polymorphism and alcoholism. Am J Med Genet 2001;105:446-450.
20. Stuppaeck CH, Barnas C, Falk M, Guenther V, Hummer M, Oberbauer H, Pycha R, Whitworth AB, Fleischhacker WW: Assessment of the alcohol withdrawal syndrome - validity and reliability of the translated and modified Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-A). Addiction 1994;89:1287-1292.
21. Goodwin GM: The effects of antidepressant treatments and lithium upon 5-HT1A receptor function. Prog Neuropsychopharmacol Biol Psychiatry 1989;13:445-451.
22. Jolas T, Schreiber R, Laporte AM, Chastanet M, De Vry J, Glaser T, Adrien J, Hamon M: Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J Pharmacol Exp Ther 1995;272:920-929.
23. Lucki I, Singh A, Kreiss DS: Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Rev 1994;18:85-95.
24. Julius D: Molecular biology of serotonin receptors. Annu Rev Neurosci 1991;14:335-360.
25. Kobilka BK, Frielle T, Collins S, Yang-Feng T, Kobilka TS, Francke U, Lefkowitz RJ, Caron MG: An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 1987;329:75-79.
26. Huang YY, Battistuzzi C, Oquendo MA, Harkavy-Friedman J, Greenhill L, Zalsman G, Brodsky B, Arango V, Brent DA, Mann JJ: Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology. Int J Neuropsychopharmacol 2004;7:441-451.
27. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, Sequeira A, Kushwaha N, Morris SJ, Basak A, Ou XM, Albert PR: Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003;23:8788-8799.
28. Rothe C, Gutknecht L, Freitag C, Tauber R, Mossner R, Franke P, Fritze J, Wagner G, Peikert G, Wenda B, Sand P, Jacob C, Rietschel M, Nothen MM, Garritsen H, Fimmers R, Deckert J, Lesch KP: Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Int J Neuropsychopharmacol 2004;7:189-192.
29. Strobel A, Gutknecht L, Rothe C, Reif A, Mossner R, Zeng Y, Brocke B, Lesch KP: Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits. J Neural Transm 2003;110:1445-1453.
30. Koller G, Bondy B, Preuss UW, Zill P, Soyka M: The C(-1019)G 5-HT1A promoter polymorphism and personality traits: no evidence for significant association in alcoholic patients. Behav Brain Funct 2006;2:7.
31. Lee ST, Park JH, Kim M: Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study. Headache 2005;45:1004-1011.
32. Brousse G, Schmitt A, Chereau I, Eschalier A, Dubray C, Llorca PM: Interest of the use of pindolol in the treatment of depression (in French). Encephale 2003;29:338-350.
33. Frazer A, Maayani S, Wolfe BB: Subtypes of receptors for serotonin. Annu Rev Pharmacol Toxicol 1990;30:307-348.
34. Amara SG, Kuhar MJ: Neurotransmitter transporters: recent progress. Annu Rev Neurosci 1993;16:73-93.
35. Blakely RD, De Felice LJ, Hartzell HC: Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 1994;196:263-281.
36. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD: Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 1993;90:2542-2546.
37. Hammoumi S, Naassila M, Daoust M: Experimental findings in the study of the reduction of alcohol intake. Eur Neuropsychopharmacol 1997;7(suppl 3):S337-S340.
38. Sander T, Harms H, Lesch KP, Dufeu P, Kuhn S, Hoehe M, Rommelspacher H, Schmidt LG: Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence. Alcohol Clin Exp Res 1997;21:1356-1359.
39. Parsian A, Cloninger CR: Serotonergic pathway genes and subtypes of alcoholism: association studies. Psychiatr Genet 2001;11:89-94.
40. Choi IG, Kee BS, Son HG, Ham BJ, Yang BH, Kim SH, Lee JS, Son BK, Lee BY, Lee SY, Chai YG, Shin HD: Genetic polymorphisms of alcohol and aldehyde dehydrogenase, dopamine and serotonin transporters in familial and non-familial alcoholism. Eur Neuropsychopharmacol 2006;16:123-128.
41. Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickar D: A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Mol Psychiatry 1998;3:328-332.
42. Golimbet VE, Alfimova MV, Shchebatykh TV, Abramova LI, Kaleda VG, Rogaev EI: Serotonin transporter polymorphism and depressive-related symptoms in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004;126:1-7.